Cover Image

Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro

ABSTRACTRozanolixizumab is a humanized anti-neonatal Fc receptor (FcRn) monoclonal antibody (mAb) of the immunoglobulin G4 (IgG4) sub-class, currently in clinical development for the treatment of IgG autoantibody-driven diseases. This format is frequently used for therapeutic mAbs due to its intrins...

Full description

Saved in:
Bibliographic Details
Main Authors: Omar S. Qureshi (Author), Emma J. Sutton (Author), Rosemary F. Bithell (Author), Shauna M. West (Author), Rona M. Cutler (Author), Gillian McCluskey (Author), Graham Craggs (Author), Asher Maroof (Author), Nicholas M. Barnes (Author), David P. Humphreys (Author), Stephen Rapecki (Author), Bryan J. Smith (Author), Anthony Shock (Author)
Format: Book
Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items